Zacks Investment Research on MSN
Here's how much a $1000 investment in ResMed made 10 years ago would be worth today
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact ...
ResMed (RMD) shares recently moved after an earnings report that showed a beat on EPS estimates while revenue matched expectations. Management described fiscal 2026 as off to a strong start. See our ...
Read RESMED CDI 10:1 [RMD] (RMD.AX) Q1 FY2026 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...
StockStory.org on MSN
Reflecting on patient monitoring stocks’ Q3 earnings: ResMed (NYSE:RMD)
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...
Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0% Income from operations increased 15%; non-GAAP ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback